- Home
- LXRX vs MPLN Comparison
LXRX vs MPLN Comparison
Compare LXRX & MPLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- MPLN
- Stock Information
- Founded
- LXRX 1995
- MPLN 1980
- Country
- LXRX United States
- MPLN United States
- Employees
- LXRX N/A
- MPLN N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- MPLN Business Services
- Sector
- LXRX Health Care
- MPLN Consumer Discretionary
- Exchange
- LXRX Nasdaq
- MPLN Nasdaq
- Market Cap
- LXRX 283.7M
- MPLN 229.8M
- IPO Year
- LXRX 2000
- MPLN N/A
- Fundamental
- Price
- LXRX $0.71
- MPLN $29.28
- Analyst Decision
- LXRX Buy
- MPLN Hold
- Analyst Count
- LXRX 2
- MPLN 2
- Target Price
- LXRX $4.00
- MPLN $26.25
- AVG Volume (30 Days)
- LXRX 4.1M
- MPLN 151.9K
- Earning Date
- LXRX 03-10-2025
- MPLN 02-25-2025
- Dividend Yield
- LXRX N/A
- MPLN N/A
- EPS Growth
- LXRX N/A
- MPLN N/A
- EPS
- LXRX N/A
- MPLN N/A
- Revenue
- LXRX $5,229,000.00
- MPLN $942,614,000.00
- Revenue This Year
- LXRX $842.94
- MPLN N/A
- Revenue Next Year
- LXRX $19.76
- MPLN $1.16
- P/E Ratio
- LXRX N/A
- MPLN N/A
- Revenue Growth
- LXRX 886.60
- MPLN N/A
- 52 Week Low
- LXRX $0.62
- MPLN $4.80
- 52 Week High
- LXRX $2.83
- MPLN $48.80
- Technical
- Relative Strength Index (RSI)
- LXRX 43.33
- MPLN 81.44
- Support Level
- LXRX $0.66
- MPLN $22.10
- Resistance Level
- LXRX $0.97
- MPLN $23.87
- Average True Range (ATR)
- LXRX 0.07
- MPLN 2.45
- MACD
- LXRX -0.00
- MPLN 0.50
- Stochastic Oscillator
- LXRX 16.13
- MPLN 95.54
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
About MPLN MultiPlan Corporation
MultiPlan Corp is a provider of data analytics and technology-enabled solutions designed to bring affordability, efficiency, and fairness to the U.S. healthcare industry. The company interprets clients' needs and customizes solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry.